Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug. - Wikidata - awgldk - TriplyDB

Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug.

Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug.

http://www.wikidata.org/entity/Q33920919

about

Expansion of human γδ T cells for adoptive immunotherapy using a bisphosphonate prodrug.Human γδ T-Cell Control of Mucosal Immunity and Inflammation.Gamma Delta T Cell Therapy for Cancer: It Is Good to be Local.Improving the Efficiency of Vγ9Vδ2 T-Cell Immunotherapy in Cancer.Protective Role of T Cells in Different Pathogen Infections and Its Potential Clinical Application γδ T Cells in Antimalarial Immunity: New Insights Into Their Diverse Functions in Protection and Tolerance

P2860

Q47666620-8CC158BA-8BC6-4BD8-9F14-C6E3ED38F552 Q55006062-FD026C98-FC99-4F7A-B994-7C16839A1E5F Q55223108-754BFFA6-AC05-4FE6-B217-65EBDC8CA272 Q55311835-B21AAAEC-BC05-4587-924F-4281D2C4828D Q57024595-5356B14D-B9DF-4FA4-B0D4-077C9D9762E9 Q58572524-1DCB7E17-9E25-4855-B292-8E07A8AC0A47

P2860

Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug.

http://www.wikidata.org/entity/Q33920919

description

2017 nî lūn-bûn

@nan

2017 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug.

@ast

Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug.

@en

type

label

Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug.

@ast

Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug.

@en

prefLabel

Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug.

@ast

Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug.

@en

P1433

Q33920919-FD33D222-D753-4265-B2BB-541F3F1F35BE

P1476

Q33920919-C9625E5F-3581-4F68-B936-E55D832D88B1

P2093

Q33920919-5C5DACDC-86EB-478C-BB54-2B4435A6C0C7

Q33920919-5C9AF9E5-320D-45AF-BEC6-6A6622EAD886

Q33920919-5DA2A225-4844-4A07-95D3-F2424B2B3C56

Q33920919-6F30080B-C1E8-44D8-BFC5-69602745905D

Q33920919-80B5DE4C-E8DA-4450-94DD-83939B74665C

Q33920919-814FDB85-286D-4FDC-A9C8-D7545434F365

Q33920919-D90E2A0D-35D1-4107-B16E-8AA5072C8366

Q33920919-FBA040D4-DB8E-41A7-8699-39CE9DAD696E

P2860

Q33920919-0416769B-30FA-4CEE-842B-9A041839AA2F

Q33920919-0FFCB70B-DB66-4E35-A0A3-66B23139BAC0

Q33920919-148F12FF-C72F-4DAD-ACAD-77E6C88DBEE9

Q33920919-15DFE898-94FB-44CA-8175-240B9BB8F37A

Q33920919-1B4E90C1-6CBD-4127-9BD6-41295F8406EC

Q33920919-1E802433-F0A1-4269-AFB7-AD2BB3D6BF1D

Q33920919-200ACA68-A515-481D-9670-2187CC696C8E

Q33920919-2707FB2F-1703-4E57-A60E-6F0F0200A22C

Q33920919-3276807D-10BF-4D16-A0F2-4E42736ED974

Q33920919-34748AC8-7ACC-4CB9-878E-531E5608849B

P2888

Q33920919-034567AC-AC2E-45C4-B2E3-7343E87703F8

P304

Q33920919-AE19A05B-271C-4DCD-89E3-D4DCA52C4C82

P31

Q33920919-26AA1DA9-B4BC-4F5D-85EE-174360B6A78A

P356

Q33920919-A09DAFD5-BAF6-49BE-AEFB-8C67C3BA946C

P407

Q33920919-C985F499-4CF4-4D06-9F17-7A264310C721

P433

Q33920919-39DEB2FE-8DFE-481F-8422-6772FCAB99FB

P478

Q33920919-B03980A7-B749-40A2-835D-BA3DC4F078B8

P50

Q33920919-104BB835-AD8A-4E69-B73A-B90C682700BD

Q33920919-5314D16A-5D7F-47C8-9E18-E5FD279391AF

P577

Q33920919-69D2D346-1A28-4480-BBBA-9CF148FC8948

P6179

Q33920919-C41A4BFE-851D-4287-B446-B360580ED2A6

P698

Q33920919-06D9691A-CA02-4806-A37C-3EF4B5E9B4B4

P921

Q33920919-D98B4EB2-9734-4D5D-976E-4B0C37B7CA31

P932

Q33920919-2DF10C66-CC19-4479-B875-27E450F80BA5

P356

S41598-017-05553-0

P1433

Scientific Reports

P1476

Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug.

@en

P2093

Haruki Okamura

http://www.w3.org/2001/XMLSchema#string

Kaoru Murata-Hirai

http://www.w3.org/2001/XMLSchema#string

Kenji Matsumoto

http://www.w3.org/2001/XMLSchema#string

Kosuke Hayashi

http://www.w3.org/2001/XMLSchema#string

Masakazu Toi

http://www.w3.org/2001/XMLSchema#string

Masashi Iwasaki

http://www.w3.org/2001/XMLSchema#string

Nagahiro Minato

http://www.w3.org/2001/XMLSchema#string

Tomoharu Sugie

http://www.w3.org/2001/XMLSchema#string

P2860

Development of bisphosphonates.

Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset

Prodrugs of phosphonates and phosphates: crossing the membrane barrier

Inhibition of Geranylgeranyl Diphosphate Synthase by Bisphosphonates: A Crystallographic and Computational Investigation †

Chemo-Immunotherapeutic Antimalarials Targeting Isoprenoid Biosynthesis

The Intracellular B30.2 Domain of Butyrophilin 3A1 Binds Phosphoantigens to Mediate Activation of Human Vγ9Vδ2 T Cells

Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase

Targeting human {gamma}delta} T cells with zoledronate and interleukin-2 for immunotherapy of hormone-refractory prostate cancer

Butyrophilin 3A1 plays an essential role in prenyl pyrophosphate stimulation of human Vγ2Vδ2 T cells

Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates.

P2888

s41598-017-05553-0

P304

5987

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-05553-0

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Yoshimasa Tanaka

P577

2017-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1090717746

http://www.w3.org/2001/XMLSchema#string

P698

28729550

http://www.w3.org/2001/XMLSchema#string

P921

P932

5519590

http://www.w3.org/2001/XMLSchema#string